You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,962,603


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,962,603 protect, and when does it expire?

Patent 8,962,603 protects ELLA and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 8,962,603
Title:Method for post coital contraception in overweight or obese female subjects using ulipristal acetate
Abstract: The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
Inventor(s): Levy; Delphine (Paris, FR), Ulmann; Andre (Paris, FR), Mathe; Henri Camille (Paris, FR), Gainer; Erin (Paris, FR)
Assignee: Laboratoire HRA-Pharma (Paris, FR)
Application Number:13/575,086
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,962,603
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,962,603

Introduction

United States Patent 8,962,603, like any other patent, is a complex document that outlines the invention, its scope, and the claims that define the intellectual property protected by the patent. To analyze this patent, we need to delve into its various components, including the background, summary, detailed description, and most importantly, the claims.

Background and Summary

Before diving into the specifics of the patent claims, it is essential to understand the context and purpose of the invention. The background section typically provides an overview of the existing technology and the problems it addresses, while the summary section gives a brief description of the invention.

Detailed Description

The detailed description section is where the inventor explains the invention in detail, often including drawings and diagrams. This section helps in understanding how the invention works and its various components.

Patent Claims

The claims are the most critical part of a patent as they define the scope of the invention and what is protected by the patent.

Independent and Dependent Claims

Patent claims are categorized into independent and dependent claims. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to an independent claim and further limit the scope of the invention[3].

Claim Language and Scope

The scope of a patent is often measured by metrics such as independent claim length and independent claim count. These metrics can indicate the breadth of the patent claims. For instance, narrower claims with fewer independent claims might suggest a more focused and specific invention, while broader claims could indicate a more general and potentially overly broad invention[3].

Analyzing Patent 8,962,603

Title and Abstract

To start, one would look at the title and abstract of the patent to get a high-level understanding of what the invention is about.

Background of the Invention

The background section would provide context on the existing technology and the problems the invention aims to solve.

Summary of the Invention

The summary section would give a concise overview of the invention, highlighting its key features and improvements over existing technologies.

Detailed Description of the Invention

This section would include detailed explanations, diagrams, and descriptions of how the invention works. It would cover the various components, their interactions, and any specific methodologies or processes involved.

Claims

  • Independent Claims: These would define the core aspects of the invention without referencing other claims.
  • Dependent Claims: These would further limit the scope of the independent claims, adding specific details or conditions.

Example Analysis

Claim Structure

For example, if Patent 8,962,603 is related to a technological innovation, the independent claims might describe the overall system or method, while the dependent claims might specify particular components or steps involved in the method.

Scope and Breadth

The analysis would involve determining whether the claims are narrow and specific or broad and general. This can be done by examining the claim language, the number of independent and dependent claims, and how they interact to define the invention's scope.

Patent Landscape and Implications

Prior Art and Novelty

Understanding the prior art in the field is crucial to assessing the novelty and non-obviousness of the invention. This involves searching existing patents and publications to ensure that the invention is new and not obvious to someone skilled in the art[1].

Patent Family and Global Dossier

Using tools like the Global Dossier provided by the USPTO, one can see the patent family for a specific application, including all related applications filed at participating IP Offices. This helps in understanding the global landscape and any potential overlaps or conflicts with other patents[1].

Recent Updates and Guidelines

For patents involving AI or software-related inventions, the 2024 USPTO guidance update on AI patent eligibility would be relevant. This update clarifies how to determine the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications[4].

Determining Inventorship

Correctly identifying the inventors is crucial for the validity of the patent. The US patent law requires that only the true and only inventors be listed on the patent application. Errors in inventorship can lead to the patent being invalid or unenforceable if done with deceptive intent[5].

Practical Applications and Real-World Benefits

To ensure patent eligibility, especially for AI-related inventions, it is essential to demonstrate how the abstract idea is applied in a practical manner. This involves showing that the claimed invention provides concrete benefits or solves specific problems in the relevant field[4].

Key Takeaways

  • Patent Claims: The claims are the heart of a patent, defining what is protected.
  • Scope and Breadth: Narrower claims often indicate a more focused invention, while broader claims can be more general.
  • Prior Art and Novelty: Ensuring the invention is new and non-obvious is critical.
  • Global Landscape: Using tools like the Global Dossier helps in understanding the global patent landscape.
  • Inventorship: Correctly identifying inventors is vital for patent validity.
  • Practical Applications: Demonstrating real-world benefits is essential for patent eligibility.

FAQs

Q: What is the significance of independent and dependent claims in a patent? A: Independent claims define the invention without referencing other claims, while dependent claims further limit the scope of the independent claims, adding specific details or conditions.

Q: How does the USPTO's Global Dossier help in patent research? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family, dossier, classification, and citation data for these applications.

Q: What are the key points from the 2024 USPTO guidance update on AI patent eligibility? A: The update emphasizes evaluating whether a claim integrates a judicial exception into a practical application, clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, and incorporates recent case law and new examples specifically tailored to AI technologies.

Q: Why is correct inventorship important in patent applications? A: Correct inventorship is crucial because errors can lead to the patent being invalid or unenforceable if done with deceptive intent. Only the true and only inventors should be listed on the patent application.

Q: How do you determine the scope and breadth of a patent? A: The scope and breadth can be determined by analyzing the claim language, the number of independent and dependent claims, and how they interact to define the invention's scope. Metrics such as independent claim length and count can also be used.

Sources

  1. USPTO: Search for patents - USPTO.
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov.
  3. SSRN: Patent Claims and Patent Scope.
  4. Mintz: Understanding the 2024 USPTO Guidance Update on AI Patent.
  5. Oregon State University: Determining Inventorship for US Patent Applications.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,962,603

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lab Hra Pharma ELLA ulipristal acetate TABLET;ORAL 022474-001 Aug 13, 2010 AB RX Yes Yes 8,962,603 ⤷  Subscribe METHOD FOR PROVIDING POST COITAL CONTRACEPTION TO A WOMAN BY ADMINISTERING ABOUT 30 MG OF ULIPRISTAL ACETATE WITHIN ABOUT 120 HOURS AFTER INTERCOURSE, WHEREIN THE WOMAN IS OVERWEIGHTHAVING A BMI OF 25 TO 29.99 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,962,603

PCT Information
PCT FiledDecember 01, 2010PCT Application Number:PCT/EP2010/068646
PCT Publication Date:August 04, 2011PCT Publication Number: WO2011/091890

International Family Members for US Patent 8,962,603

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2011091890 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.